OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
April 13, 2021
Writing at the intersection of managed markets and the pharmaceutical industry.
March 24, 2021
On examination of the challenge and strategies, lack of adherence is in and of itself a preventable disease.
January 29, 2021
Winning in the 20s: How access needs to evolve.
January 26, 2021
Patient Assistance Programs (PAPs) came out of the shadows in 2020 as several factors aligned that increased demand and awareness of these programs.
January 05, 2021
Taking a closer look at the evolving legal treatment of coupons and copay accumulators.
December 15, 2020
Outlining the steps to a payment approach for Medicare Part D drugs that provides savings for patients.
December 11, 2020
2020 has proven to be a year like no other for pharma. Here is a quick look back at some of the trends 2020 created for the industry.
December 09, 2020
If telehealth is here to stay, how is the industry adjusting?
December 03, 2020
How technology can maximize use of manufacturer copay and patient assistance programs.
November 16, 2020
The importance of life sciences companies focused on rare diseases to take early steps to bridge connections with patients, caregivers, and healthcare providers.